Endocrine Management and Clinical Outcomes in a Cohort of Pediatric Patients Undergoing Total Pancreatectomy with Islet Autotransplantation.

To describe management strategies that contributed to optimal outcomes in pediatric recipients of a total pancreatectomy with islet autotransplantation (TPIAT). We provide a comprehensive report of the approach to endocrine management of the pediatric TPIAT recipient from initial evaluation through the first 4 years postsurgery. We performed a retrospective review of the endocrine outcomes of TPIAT recipients to describe the impact of this approach on post-TPIAT glycemic management. Outcome data from 86 TPIAT recipients were reviewed. At 12 months post-TPIAT ( = 82), the median HbA1C was 6.0% (25-75th percentile 5.6-6.7), at 18 months ( = 56) HbA1C was 6.4% (5.6-7.5), at 2 years ( = 46) HbA1C was 6.4% (5.6-7.4), at 3 years ( = 31) HbA1C was 6.5% (5.5-8.1), and at 4 years ( = 16) HbA1C was 7.2% (6.2-8.3). Pediatric patients at our institution have favorable endocrine outcomes as evidenced by median HbA1C under the goal of 6.5% through the initial 3 years by following our modified management protocols.